New York, USA – December 9, 2022 – Drosophila Center, the division of CD BioSciences, is a pioneer in Drosophila research focusing on micro-injection, genome editing, cell engineering, genetics, metabolism, neurobiology, and other fields. With a mission to provide high-quality and affordable Drosophila products and services, CD BioSciences with a team of experienced experts develops solutions by precise genetic modification of Drosophila as humanized models, as well as diverse phenotypes analysis for fundamental research and drug discovery. Recently, CD BioSciences announced the release of its flexible Drosophila microinjection service to support the study of drug metabolism, toxicology, and other derivative services.
Relying on professional microinjection equipment and a technical team, CD BioSciences provides highly reliable and efficient professional microinjection services to solve technical challenges and bottlenecks in research. CD BioSciences offers a variety of microinjection services for different developmental stages and sites of Drosophila, including nucleic acid substances, drugs or inhibitors, dyes, and Wolbachia (or other) infectious agents, conducting recording and professional pilot experiments to address various injection parameters.
In addition, CD BioSciences helps customers achieve rapid equilibration to maintain deleterious mutations in Drosophila and ensure that recombination and loss do not occur, rich equilibrium inventories and specialized next-generation sequencing platforms can stably protect individual deleterious alleles, and can also use carryover dominantly-marked balanced chromosomes to aid clients in descending phenotypic screening.
CD BioSciences is dedicated to expanding basic life science research in Drosophila. With a team with many years of research experience, we provide customized research services for Drosophila to global customers, solving the technical challenges and fortresses of research topics. CD BioSciences builds advanced equipment and technology platforms that support the design of integrated solutions ranging from Drosophila microinjection, stable model construction, and large-scale chemical and functional screening to Drosophila optogenetics.
CD BioSciences has extensive experience in the Drosophila field and offers clients a wide range of services and products covering the entire process of using a suitable and efficient gateway. Relying on the professional platform, CD BioSciences has successfully completed several Drosophila-based research projects.
“We provide customers with flexible custom microinjection services that can inject a variety of exogenous substances to obtain processed samples of each developmental stage or tissue in Drosophila.” said Marcia Brady, the marketing director of CD BioSciences, she also added, “We insist on mastering cutting-edge technology, providing the most intimate and high-quality services, and accelerating the research progress of each customer.”
About CD BioSciences
With a mission to provide high-quality and affordable Drosophila products and services, CD BioSciences with a team of experienced experts develops solutions by precise genetic modification of Drosophila as humanized models, as well as diverse phenotypes analysis for fundamental research and drug discovery.
Media ContactCompany Name: CD BioSciencesContact Person: Marcia BradyEmail: Send EmailPhone: 1-631-372-1052Country: United StatesWebsite: https://www.drosophilidae.com
